CMX 2043
Alternative Names: CMX-2043Latest Information Update: 01 Sep 2023
At a glance
- Originator Ischemix
- Class Cytoprotectives; Ischaemic heart disorder therapies; Small molecules
- Mechanism of Action Proto oncogene protein c akt modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Phase II Reperfusion injury
- Phase I Traumatic brain injuries